Erlib 150mg Tablet
Marketer
Neon Laboratories Ltd
Salt Composition
Erlotinib (150mg)
Overview Erlib 150mg Tablet
Erlib 150mg tablets treat non-small cell lung and pancreatic cancers. Administer on an empty stomach, or one hour before or two hours after eating. Continue treatment as directed by your physician; duration depends on individual response. Follow your doctor's instructions precisely; improper use or overdose can lead to severe adverse effects. Benefits may take weeks or months to appear; do not discontinue without consulting your doctor. Common side effects include nausea, vomiting, tiredness, skin rash, and weight loss. Severe diarrhea requires increased fluid intake or medical attention. Photosensitivity may occur; use sunscreen and protective clothing outdoors. Report mouth sores, vision changes, or breathing problems immediately. Liver function monitoring may be recommended. Inform your healthcare provider of all other medications you're taking, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; effective contraception is crucial for both partners. Smoking cessation is advised as it can interfere with treatment efficacy. Maintain a two-hour interval between Erlib and antacids or other medications.
Uses of Erlib 150mg Tablet
Cancers of the pancreas and non-small-cell lungs
Major Benefits of Erlib 150mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Erlib 150mg Tablets should be taken on an empty stomach.
Common Side effects of Erlib 150mg Tablet:
- Abdominal pain
- Bone pain
- Breathlessness
- Constipation
- Cough
- Diarrhea
- Fatigue
- Fever
- Infection
- Muscle pain
- Nausea
- Rash
- Stomatitis (Inflammation of the mouth)
- Vomiting
- Weight loss
How to use Erlib 150mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the entire tablet without chewing, crushing, or fracturing it. Erlib 150mg tablets should be taken on an empty stomach.
How Erlib 150mg Tablet works:
Erlib 150mg tablets are used in cancer treatment. Lung cancer cells possess epidermal growth factor receptors (EGFRs) which regulate their proliferation. The drug functions by attaching to these EGFRs, thereby blocking the EGFR-driven cancer cell growth signals and halting tumor expansion.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Erlib 150mg Tablet lacks established safety data. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Erlib 150mg tablets during pregnancy poses a confirmed risk to the unborn child. Therefore, it's contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Lactation and Erlib 150mg tablets are likely incompatible. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
Driving ability may be unaffected by Erlib 150mg Tablet; however, refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
For patients with kidney disease, Erlib 150mg Tablet is considered safe and requires no dosage alteration. However, its use is contraindicated in individuals with severely impaired kidney function.
LiverCAUTION
Patients with hepatic impairment should use Erlib 150mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Erlib 150mg Tablet :
Omit any missed Erlib 150mg Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Erlib 150mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Quinazoline-based compound |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
3,018 People bought this recently